Les Szancer, Blueribbonoptionsonline.com
HOLD RECOMMENDATIONS
Chart: Share price over the year to versus ASX200 (XJO)
The company powers on with its cancer treatment trials getting ever closer to US approval. The shares have fallen since listing on the NASDAQ in April. The CEO is moving on, but remaining a director. Replacement Matthew Lehman has extensive experience in this field.
Les Szancer, Blueribbonoptionsonline.comHOLD...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.015(5.36%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 30.5¢ | 28.0¢ | $833.4K | 2.824M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 388130 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 39940 | 3 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |